326 related articles for article (PubMed ID: 22627058)
1. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
[TBL] [Abstract][Full Text] [Related]
4. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
7. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
[TBL] [Abstract][Full Text] [Related]
8. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
9. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
[TBL] [Abstract][Full Text] [Related]
11. The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood.
Barroeta Seijas AB; Graziani S; Cancrini C; Finocchi A; Ferrari S; Miniero R; Conti F; Zuntini R; Chini L; Chiarello P; Bengala M; Rossi P; Moschese V; Di Matteo G
Int J Immunopathol Pharmacol; 2012; 25(2):407-14. PubMed ID: 22697072
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
[TBL] [Abstract][Full Text] [Related]
13. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
14. TACI is mutant in common variable immunodeficiency and IgA deficiency.
Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
[TBL] [Abstract][Full Text] [Related]
15. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
16. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.
Salzer U; Chapel HM; Webster AD; Pan-Hammarström Q; Schmitt-Graeff A; Schlesier M; Peter HH; Rockstroh JK; Schneider P; Schäffer AA; Hammarström L; Grimbacher B
Nat Genet; 2005 Aug; 37(8):820-8. PubMed ID: 16007087
[TBL] [Abstract][Full Text] [Related]
17. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
Waldrep ML; Zhuang Y; Schroeder HW
BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
[TBL] [Abstract][Full Text] [Related]
18. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
Berglund LJ; Jones GJ; Murali R; Fulcher DA
J Allergy Clin Immunol; 2006 Apr; 117(4):870-7. PubMed ID: 16630947
[TBL] [Abstract][Full Text] [Related]
19. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).
Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R
J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507
[TBL] [Abstract][Full Text] [Related]
20. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.
Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE
J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
